AREDS Vision Supplement: 7 Checks on How TheyaVue Compares

Written by the Mytheyavue Editorial Desk · Medically reviewed by Dr. Joanna Slusky, OD, Optometrist · Reviewed October 16, 2026

Quick answer

No. TheyaVue is not an AREDS2 formula. Of the six trial nutrients, its label matches only copper. It gives less vitamin C, vitamin E and zinc, and it prints no amount for lutein or zeaxanthin. AREDS2 also tested people who already had intermediate or advanced macular degeneration. Seven checks show the gap.

Written by the Mytheyavue Editorial DeskMedically reviewed by Dr. Joanna Slusky, ODLast updated October 16, 2026

AREDS and macular supplements

Is TheyaVue an AREDS vision supplement?

The words AREDS and macular supplements appear on a great many bottles. Searches such as vision supplement AREDS, macular supplement and macular supplements with lutein all lead toward one trial. Many shoppers also ask, do macular supplements work? The honest answer starts with that trial, so we start there too.

TheyaVue does not claim to be the trial formula. But its pages and many others in this field lean on the trial's good name. A fair look means setting the label next to the real study and counting what matches.

We use the label, the seller notes and the trial sources named in our files. The checks go in order, from the study itself to what the study means for you.

Key facts

AREDS2 was a National Eye Institute trial in 4,203 people aged 50 to 85. All had intermediate or advanced age-related macular degeneration (AMD) when they joined.
The trial formula, per day: vitamin C 500 mg, vitamin E 400 IU, lutein 10 mg, zeaxanthin 2 mg, zinc 80 mg (25 mg in a second arm) and copper 2 mg.
TheyaVue, per day at two capsules: vitamin C 200 mg, vitamin E 20 mg (about 44 IU), zinc 32 mg, copper 2 mg. Lutein and zeaxanthin have no published amount.
The trial slowed the disease in its tested group. Sight did not get sharper, and people with early AMD or none saw no gain.
TheyaVue is not FDA approved, and no supplement is.

TheyaVue bottle with 60 vegetable capsules

If you want to see the full panel next to these numbers, the order page shows the product and the 60-day terms.

See today's price and guarantee

Mytheyavue earns money when you buy through the order links on this site.

Plain note

This product is sold as a supplement, which is a different thing from a drug. It is not FDA approved, and it is not intended to diagnose, treat, cure or prevent macular degeneration or any other disease. If you have an eye condition, your eye doctor decides what to take. Sudden blurring, flashes, floaters, eye pain or vision loss need an eye doctor the same day.

Check 1

Check 1: Who ran AREDS2, and how good was the design?

AREDS2 is the second Age-Related Eye Disease Study. Its sponsor was the National Eye Institute, a US government research agency inside the National Institutes of Health. The study was large, randomized, double-blind and placebo-controlled, which is the bar used to judge medicines.

Why does that matter? A trial run by a supplement seller on its own formula has a built-in pull toward a happy result. AREDS2 was designed, run and published apart from any bottle on a shelf. Its results apply to the formula it tested. They do not travel to every bottle that cites it.

Check 2

Check 2: Who was in the trial?

The trial enrolled 4,203 people aged 50 to 85. To qualify, a volunteer needed a middle stage of AMD in both eyes, or a late stage in one eye and at least a middle stage in the other. Every volunteer started with a diagnosis.

People with healthy eyes were not enrolled. People with only early AMD were not enrolled either. So the trial answers one question. Can this formula slow the disease in people who already have a real amount of it? It was not built to ask whether the formula prevents AMD or helps people whose eyes are fine.

The National Eye Institute says the same in its public pages. The formula may help slow progression in people with a middle or late stage. NEI adds that data from the AREDS studies found no benefit for anyone with no AMD, or with early AMD only.

Check 3

Check 3: What was the exact formula?

Here is the formula, with every amount published. There is no blend and no hidden figure in it.

500 mg of vitamin C, as ascorbic acid.
400 IU of vitamin E, about 180 mg, as alpha-tocopherol.
10 mg of free lutein and 2 mg of free zeaxanthin.
80 mg of zinc as zinc oxide, or 25 mg in a second arm of the trial.
2 mg of copper, as cupric oxide.

Notice the last line. Copper sits next to zinc on purpose. High zinc intake can interfere with copper absorption, so the trial paired the two from the start.

Check 4

Check 4: What did the trial find, and what did it not find?

Swapping lutein and zeaxanthin in for beta-carotene did at least as well at slowing progression to advanced AMD, and it carried less lung cancer risk in former smokers. A summary of the first study describes the core formula cutting progression to advanced AMD by roughly 25% over five years in people at that middle stage.

That is a real finding in a real group. Now the limits, which marketing likes to skip.

The disease slowed. Nobody's vision got sharper.
Early AMD: no gain was shown.
Healthy eyes: no gain was shown.
Sight lost before the trial stayed lost.
Adding omega-3 fatty acids gave no extra benefit.

Check 5

Check 5: How do the numbers on the TheyaVue label line up?

Now put the two side by side. TheyaVue's amounts below are per day at the label dose of two capsules. The label is printed per capsule, so each printed figure doubles.

TheyaVue label set against the AREDS2 formula, per day
Nutrient	On the TheyaVue label	In the trial	Label as a share of trial
Vitamin C	200 mg	500 mg	40%
Vitamin E	20 mg, roughly 44 IU	400 IU, roughly 180 mg	11%
Lutein	Inside the 481 mg blend; amount not published	10 mg	Cannot be scored
Zeaxanthin	Inside the 481 mg blend; amount not published	2 mg	Cannot be scored
Zinc	32 mg	80 mg, or 25 mg in the lower arm	40%
Copper	2 mg	2 mg	100%

Only copper matches. The vitamins and zinc sit below the trial doses, and the two carotenoids cannot be checked at all. That does not make the bottle dangerous. It does mean the word AREDS describes a resemblance here and not a copy. Matching the numbers would not turn a supplement into a treatment either.

Check 6

Check 6: What about the beta-carotene on the TheyaVue label?

The first AREDS formula used beta-carotene. High doses of it were linked to more lung cancer in smokers in two large trials. The CARET trial gave smokers and asbestos-exposed workers 30 mg a day of beta-carotene with retinyl palmitate. That group had 28% more lung cancer and 46% more deaths from it than the placebo group, and the trial stopped early. The ATBC trial gave 20 mg a day to male smokers and saw 18% more lung cancer. That is why AREDS2 moved to lutein and zeaxanthin.

TheyaVue's vitamin A comes from beta-carotene, at 100 mcg RAE a day. That is roughly 0.2 mg, far below those doses. Our files see no established cancer signal at that level. If you smoke, or used to, still mention the product to a doctor before adding any separate high-dose beta-carotene.

Check 7

Check 7: Who does the result really speak to?

The trial speaks to people with intermediate or advanced AMD, who are under an eye doctor's care. It does not speak to a healthy adult who wants general support, and it does not speak for any single bottle.

So, do macular supplements work? In the tested group, a defined formula slowed the disease. For everyone else, and for formulas that differ from the trial, the trial does not say. If you have AMD, ask your eye doctor what to take. If your eyes are healthy, the trial gives no reason to expect a gain.

A simple rule

Match the six numbers, check who the label is aimed at, and ask your eye doctor. If any of the three is missing, the word AREDS on a bottle is only a name.

Frequently asked questions

Is TheyaVue an AREDS2 supplement?

No. It shares some nutrient names with the trial formula, but only its copper amount matches. The label gives less vitamin C, vitamin E and zinc, and it prints nothing for lutein or zeaxanthin.

Do macular supplements work?

Only in a narrow group. People who already had a middle or late stage of macular degeneration progressed more slowly on the AREDS2 formula. Sight did not sharpen, and early or no disease showed no gain.

Does TheyaVue contain lutein and zeaxanthin?

The label names both and the front of the bottle advertises them, but they sit inside a 481 mg daily blend with no individual amount printed.

Why did AREDS2 drop beta-carotene?

Two large trials tied high-dose beta-carotene to more lung cancer in smokers. In AREDS2, lutein and zeaxanthin did at least as well without that risk.

Should I take a macular supplement if my eyes are healthy?

The trial gives no reason to expect a gain for healthy eyes. Ask your doctor before starting, especially if you take medicine or have a medical condition.

Is TheyaVue FDA approved?

No. It is sold as a dietary supplement, and the FDA does not approve dietary supplements.

Which sources back this page?

Editorial view

Our view

AREDS2 is a careful trial with a narrow answer. That narrowness is its strength. Any bottle that borrows the name should be held to the same narrowness, and TheyaVue does not meet it on the numbers.

That said, we do not read the gap as a scandal. The label does not claim to be the trial formula. It lists a broad mix of vitamins, minerals and plant extracts under an Eye and Vision Support Formula heading. Judge it for what it is: a daily supplement with some unknowns, not a macular treatment.

If you are comfortable with that picture, the order page shows today's price and the 60-day guarantee.

See today's price and guarantee

Mytheyavue earns money when you buy through the order links on this site.

Last updated October 16, 2026